FDA Panel Votes on Intranasal Epinephrine for Treating Severe Allergic Reactions

The majority of FDA panel members voted positively regarding the benefits of neffy, an intranasal formulation of epinephrine.

Related Keywords

Richard Lowenthal ,Allergy Drug Advisory Committee ,Allergy Drug Advisory Committee Meeting ,Drug Administration ,Pulmonary Allergy Drug Advisory Committee ,